PASSIVE IMMUNOTHERAPY OF CANCER - PERSPECTIVES AND PROBLEMS

被引：9

作者：

BOS, E

BOON, P

KASPERSEN, F

MCCABE, R

机构：

[1] Organon International BV, Oss

[2] Organon Teknika Group, Rockville, MD

来源：

JOURNAL OF CONTROLLED RELEASE | 1991年 / 16卷 / 1-2期

关键词：

ANTIBODY; IMMUNOCONJUGATE; TUMOR; THERAPY; PRODRUG ACTIVATION;

D O I：

10.1016/0168-3659(91)90034-B

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

The past decade was witnessed an exponential growth in the field of immunotherapy of cancer. Efforts have been directed to obtain proof of the concept that monoclonal antibodies, by virtue of their specificity in tumour cell recognition, are ideally suitable as carrier molecules of therapeutic agents. To date, the mass studies on targeting of protein toxins, radioisotopes and drugs have not yet seen a break-through to a clinically useful therapy. A review is given on the problems still to be solved in the design of immunoconjugates for clinical use.

引用

页码：101 / 111

页数：11

共 70 条

[51]

Greenfield, Braslawsky, Oleck, Kaneko, Anthracycline immunoconjugates having a novel linker and methods for their production, (1989)

[52]

Greenfield, Senter, Danes, Fitzgerald, Gawlok, Mangler, Braslawsky, In vitro evaluation of immunoconjugates prepared by linking mitomycin c to monoclonal antibodies via polyglutamic acid carriers, Antibody, Immunoconjug. and Radiopharm., 2, pp. 201-216, (1989)

[53]

Zein, Sinha, McGahren, Ellerstad, Calicheamicin “gamma”: an antitumour antibiotic that cleaves double-stranded DNA site specifically, Science, 240, pp. 1198-1201, (1988)

[54]

New conjugates of trichothecene and agent binding to cells — when agent is antibody useful for killing defined cell populations especially of tumour cells, (1987)

[55]

Hinman, Wallace, Hamann, Durr, Upeslacis, Calicheamicin immunoconjugates: influence of analog and linker modification on activity in vivo, Antibody, Immunoconjug. Radiopharm., 3, (1990)

[56]

Sivam, Comezoglu, Vrudhula, Riker, Manger, Gray, Srinivasar, Jarvis, Morgan, Immunoconjugates of a small molecule protein synthesis inhibitor (trichothecene): an update, Antibody, Immunoconjug. Radiopharm., 3, (1990)

[57]

Bagshawe, Antibody directed enzyme prodrug therapy, Analytical Proceedings, 27, (1990)

[58]

Senter, Saulnier, Schreiber, Hirschberg, Brown, Hellstrom, Hells-trom, Antitumour effects of antibody-alkaline phosphatase conjugates in combination with etoposide phosphate, Proc. Natl. Acad. Sci. U.S.A., 85, pp. 4842-4846, (1988)

[59]

Senter, Schreiber, Hirschberg, Ashe, Hellstrom, Hellstrom, Enhancement of the in vitro and in vivo antitumour activities of phosphorylated mitomycin c and etoposide derivatives by monoclonal antibody-alkaline phosphatase conjugates, Cancer Res., 49, pp. 5789-5792, (1989)

[60]

Springer, Antoniew, Bagshawe, Searle, Melton, Sherwood, A novel approach to prodrug activation using a monoclonal antibody conjugated to carboxypeptidase G2, Abstract Third Int. Conference on Monoclonal Immunoconjugates for Cancer, (1988)

← 1 2 3 4 5 6 7 →